<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AInformation_memorandum</id>
	<title>Definition:Information memorandum - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AInformation_memorandum"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Information_memorandum&amp;action=history"/>
	<updated>2026-05-01T06:28:04Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Information_memorandum&amp;diff=17963&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Information_memorandum&amp;diff=17963&amp;oldid=prev"/>
		<updated>2026-03-15T16:30:24Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📄 &amp;#039;&amp;#039;&amp;#039;Information memorandum&amp;#039;&amp;#039;&amp;#039; — often abbreviated as IM and sometimes called a confidential information memorandum (CIM) — is a detailed document prepared by a seller or its advisors to present the strategic, financial, and operational profile of an insurance business or asset being offered for sale. In insurance [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]], the IM is the primary marketing document provided to prospective buyers after they execute a [[Definition:Non-disclosure agreement (NDA) | non-disclosure agreement]], and it is designed to give those parties enough information to formulate a credible [[Definition:Indication of interest (IOI) | indication of interest]] or [[Definition:Indicative offer | indicative offer]]. Whether the target is a specialty [[Definition:Managing general agent (MGA) | MGA]], a [[Definition:Life insurance | life insurance]] portfolio, a [[Definition:Run-off | run-off]] book, or an [[Definition:Insurtech | insurtech]] venture, the IM frames the opportunity in a way that highlights value while providing sufficient analytical depth for sophisticated buyers.&lt;br /&gt;
&lt;br /&gt;
📊 A well-constructed IM for an insurance transaction typically covers the company&amp;#039;s history, corporate structure, and regulatory status — including details about licenses held across relevant jurisdictions and supervisory relationships with bodies such as state insurance departments in the U.S., the [[Definition:Prudential Regulation Authority (PRA) | PRA]] and [[Definition:Financial Conduct Authority (FCA) | FCA]] in the UK, or equivalent authorities in Continental Europe and Asia. It will present historical financial statements, [[Definition:Combined ratio | combined ratio]] trends, [[Definition:Loss ratio | loss ratio]] analyses by line of business, [[Definition:Reserves | reserve]] adequacy summaries drawing on independent [[Definition:Actuarial report | actuarial opinions]], and [[Definition:Regulatory capital | regulatory capital]] positions under applicable frameworks such as [[Definition:Risk-based capital (RBC) | RBC]], [[Definition:Solvency II | Solvency II]], or [[Definition:C-ROSS | C-ROSS]]. For distribution-focused businesses like MGAs or [[Definition:Program administrator | program administrators]], the IM will detail [[Definition:Binding authority agreement | binding authority agreements]], carrier relationships, commission structures, and technology platforms. Investment highlights — such as favorable market positioning, diversified product mix, or proprietary data and analytics capabilities — are prominently featured, while risk factors are disclosed in a measured but candid fashion.&lt;br /&gt;
&lt;br /&gt;
🎯 The quality and completeness of the information memorandum directly influences how efficiently a transaction progresses. Buyers in the insurance space — whether strategic acquirers, [[Definition:Reinsurance | reinsurers]] seeking to acquire distribution, or [[Definition:Private equity | private equity]] sponsors building insurance platforms — rely on the IM to build their financial models, assess [[Definition:Embedded value | embedded value]], and identify areas requiring deeper [[Definition:Due diligence | due diligence]]. An IM that glosses over [[Definition:Loss development | loss development]] patterns, omits material regulatory matters, or presents projections disconnected from underwriting fundamentals will erode buyer confidence and slow the process. Conversely, a thorough IM that anticipates buyer questions — particularly around reserve volatility, reinsurance dependencies, and [[Definition:Key person risk | key person risk]] — can compress timelines and strengthen competitive tension among bidders, ultimately supporting a better outcome for the seller.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Indication of interest (IOI)]]&lt;br /&gt;
* [[Definition:Due diligence]]&lt;br /&gt;
* [[Definition:Non-disclosure agreement (NDA)]]&lt;br /&gt;
* [[Definition:Mergers and acquisitions (M&amp;amp;A)]]&lt;br /&gt;
* [[Definition:Indicative offer]]&lt;br /&gt;
* [[Definition:Data room]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>